Skip to content

Obesity and Liver Function in Oesophageal Cancer

Elucidating the Role of Obesity, Liver Function and Pathology With Overall Outcomes in Oesophageal Cancer

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04152044
Enrollment
658
Registered
2019-11-05
Start date
2019-11-01
Completion date
2020-11-01
Last updated
2019-11-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Liver Function, Obesity

Brief summary

There is an established link between sarcopenia and outcomes in oesophageal cancer. There is scant reports in the literature regarding the influences of different obesity in different compartments.

Detailed description

Oesophageal cancer rates are increasing as a result of obesity in Western society. Thr investigators are evaluating the influence of viscerala dn subcutaneous obesity on overall outcomes of the participants. In addition the investigators are evaluating if there is a correlation with Liver Function Tests and liver histopathology such as steatosis on survival in participants and post operative sequele.

Interventions

OTHERObservation of different types of obesity and liver pathology in patients undergoing and oesophagectomy

Patinets undergoing surgery

Sponsors

St. James's Hospital, Ireland
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
Yes

Inclusion criteria

* Those undergoing oesophagectomy

Exclusion criteria

* patients who only had chemotherapy/chemoradiotherapy without surgery

Design outcomes

Primary

MeasureTime frame
Overall Survival1 year
Disease free survival1 year

Countries

Ireland

Contacts

Primary ContactNoel E Donlon
donlonn@tcd.ie00353863557726

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 14, 2026